| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.68B | -2.3% | -11.9% |
| Cost of Revenue | $1.93B | +2.0% | -9.9% |
| Gross Profit | $757.0M | -11.8% | -16.6% |
| R&D Expense | $39.0M | +5.4% | +8.3% |
| SG&A Expense | $240.0M | -8.7% | -14.0% |
| Operating Income | -$327.0M | -164.8% | -164.2% |
| Interest Expense | -$65.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $286.0M | +24.3% | -42.7% |
| Accounts Receivable | $1.44B | -12.4% | -8.7% |
| Inventory | $1.42B | -2.5% | -10.8% |
| Current Assets | $3.73B | -4.8% | -3.5% |
| Total Assets | $13.52B | -6.7% | -10.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.20B | — | — |
| Investing Cash Flow | -$513.0M | — | — |
| Financing Cash Flow | -$783.0M | — | — |
| -3.2% |
| +5.8% |
| Pre-tax Income | -$393.0M | -188.9% | -189.5% |
| Income Tax | $102.0M | -7.3% | -15.0% |
| Net Income | -$494.0M | -236.1% | -253.9% |
| EPS (Basic) | -$5.92 | -238.6% | -260.4% |
| EPS (Diluted) | -$5.92 | -239.3% | -262.2% |
| $2.67B |
| +3.7% |
| -0.5% |
| Long-term Debt | $5.11B | +0.7% | -6.4% |
| Total Liabilities | $9.08B | -2.2% | -3.2% |
| Stockholders' Equity | $4.40B | -14.8% | -21.8% |